Novartis announced that Alcon, the eye care division of Novartis, will spin off to become a standalone company in an aim for the former to focus on growth.

Alcon will move its headquarters to Geneva, Switzerland with its Europe, Middle East, and Africa regional office. The planned move will occur in 2019.

The Geneva office will be used as a hub for corporate leadership with commercial functions, with close proximity to international transport links was a factor in the decision.

https://www.in-pharmatechnologist.com/Article/2018/09/11/Novartis-announces-Alcon-move-to-Switzerland-ahead-of-spin-out?utm_source=newsletter_daily&utm_medium=email&utm_campaign=11-Sep-2018&c=B5LaTvdHM6Dk2QeOQ4%2FlOpoHV4hmZZ3K&p2=